Catena Biosciences vs Yoneda Labs

Side-by-side comparison of AI visibility scores, market position, and capabilities

Yoneda Labs leads in AI visibility (36 vs 32)

Catena Biosciences

EmergingHealthcare

General

US YC W21 protein conjugation technology for homogeneous ADCs and biologics at $9.1M total ($2.35M seed May 2024 LongeVC/Caffeinated) and $750K revenue Jun 2025; MPC platform competing with Ajinomoto and Abzena for precise ADC conjugation services.

AI VisibilityBeta
Overall Score
D32
Category Rank
#418 of 1167
AI Consensus
50%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
25
Gemini
39

About

Catena Biosciences is a United States-based biotechnology company — backed by Y Combinator (W21) with $9.1 million in total funding including a $2.35 million seed round in May 2024 from LongeVC, CA Innovation Fund, Civilization Ventures, Pioneer Fund, Freeflow Ventures, Caffeinated Capital, and BrightEdge Capital, plus NIH SBIR grants — developing next-generation protein conjugation technology that enables the rapid, selective attachment of functional payloads (drugs, labels, polymers, other proteins) to therapeutic proteins using natural amino acids as conjugation handles, generating $750,000 in annual revenue as of June 2025 and serving pharmaceutical companies and researchers developing antibody-drug conjugates (ADCs), bispecific antibodies, vaccine adjuvants, and next-generation protein therapeutics for autoimmune disorders, oncology, and infectious disease.

Full profile

Yoneda Labs

EmergingHealthcare

General

AI chemical reaction optimization with 95% accuracy for drug discovery synthesis parameters; $4.5M from Khosla Ventures and YC competing to automate pharmaceutical process chemistry development.

AI VisibilityBeta
Overall Score
D36
Category Rank
#999 of 1167
AI Consensus
53%
Trend
stable
Per Platform
ChatGPT
44
Perplexity
32
Gemini
30

About

Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists with AI systems that determine optimal reaction parameters (temperature, solvent, catalyst, concentration) for new chemical synthesis routes, achieving 95% accuracy in suggesting effective conditions for small-scale trials. Founded in 2023 and backed by Khosla Ventures, 468 Capital, 500 Global, and Y Combinator with $4.5 million raised including a $4 million seed round in April 2024, Yoneda Labs brings mathematical category theory foundations (the name references Yoneda's lemma in category theory) to chemistry AI.

Full profile

AI Visibility Head-to-Head

32
Overall Score
36
#418
Category Rank
#999
50
AI Consensus
53
stable
Trend
stable
39
ChatGPT
44
25
Perplexity
32
39
Gemini
30
42
Claude
47
25
Grok
33

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.